Pulmonary Arterial Hypertension
📧 Sign up to get email alerts when something new happens for Pulmonary Arterial Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System
A completed clinical trial evaluated whether educational training via INSIGHT improves adherence to inhaled treprostinil (Ventavis) in patie…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension [Phase 2]
The document reports Phase 2 trial results on Terbogrel for primary pulmonary hypertension, focusing on safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Safety of Terbogrel in Patients With Primary Pulmonary Hypertension [Phase 2]
Phase 2 safety update on terbogrel in patients with pulmonary arterial hypertension; the trial was terminated.
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: Oral Iron Supplementation in Pulmonary Hypertension [NA]
A completed clinical trial evaluating oral iron supplementation in patients with pulmonary arterial hypertension.
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children [Phase 3]
Long-term safety data from a Phase 3 extension study of sildenafil citrate in children with pulmonary arterial hypertension has been complet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension [Phase 4]
Phase 4 trial update examining the safety of switching patients from bosentan to ambrisentan in pulmonary arterial hypertension; results hav…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Dichloroacetate (DCA) for the Treatment of Pulmonary Arterial Hypertension [Phase 1]
Phase 1 clinical trial evaluating dichloroacetate (DCA) for pulmonary arterial hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension [Phase 3]
A Phase 3 trial evaluating macitentan in patients with symptomatic pulmonary arterial hypertension has completed, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05 [Phase 2]
Aires Pharmaceuticals reports termination of a long-term Phase 2 study of AIR001 in adults with WHO Group 1 pulmonary arterial hypertension …
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH) [Phase 2]
A Phase 2 study evaluating AIR001 for pulmonary arterial hypertension was terminated; no results are provided in the document.
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Trimetazidine in Pulmonary Artery Hypertension [Phase 2]
Phase 2 clinical trial update evaluating trimetazidine for pulmonary arterial hypertension; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension [Phase 2, Phase 3]
This document describes an efficacy and safety study of Sodium Tanshinone IIA Sulfonate for pulmonary hypertension, including Phase 2 and Ph…
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Multidisciplinary Collaboration Care in Pulmonary Arterial Hypertension (PAH) [NA]
This entry provides an update on a completed clinical trial evaluating multidisciplinary care approaches for pulmonary arterial hypertension…
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Bosentan for Mild Pulmonary Vascular Disease in Asd Patients. [Phase 3]
A Phase 3 clinical trial evaluating bosentan for mild pulmonary vascular disease in patients with atrial septal defect has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH) [Phase 2]
Phase 2 trial evaluating the efficacy, safety, tolerability, and pharmacokinetics of nilotinib in pulmonary arterial hypertension was termin…
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension Patients [Phase 3]
This document reports an update on a Phase 3 clinical trial evaluating the initial combination of bosentan and iloprost for pulmonary arteri…
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) [Phase 3]
Phase 3 trial update for an oral BAY63-2521 in patients with pulmonary arterial hypertension (PAH) has completed with results posted in 2014…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Pulmonary Hypertension and Imatinib
A completed clinical trial evaluating imatinib for pulmonary arterial hypertension, sponsored by The Cleveland Clinic.
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Study of Cicletanine for Pulmonary Arterial Hypertension (PAH) [Phase 2]
Phase 2 study of cicletanine for pulmonary arterial hypertension was terminated.
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension [Phase 4]
A Phase 4 study evaluating intravenous treprostinil (Remodulin) for pulmonary arterial hypertension in India was terminated.
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers [Phase 1]
A Phase 1 safety study evaluating oral aminophylline and ambrisentan, both alone and in combination, in healthy volunteers to assess tolerab…
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Estimation of Pulmonary Vascular Resistance by Contrast Echocardiography [NA]
This update reports the completion of a clinical trial from George Washington University evaluating estimation of pulmonary vascular resista…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension [Phase 4]
Phase 4 trial evaluating the efficacy and safety of adding sildenafil to bosentan for pulmonary arterial hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-20Clinical Trial Update: Measuring Blood Pressure in the Lung Circulation With Sonar Technology (Echo-Doppler) [Phase 1]
Phase 1 clinical trial evaluating Echo-Doppler sonar technology to measure blood pressure in the lung circulation for pulmonary arterial hyp…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH) [Phase 3]
A Phase 3 clinical trial investigated inhaled treprostinil sodium for severe pulmonary arterial hypertension; results were posted after comp…